February 15, 2018 / 1:19 PM / 4 months ago

BRIEF-Citius Announces Enrollment Of First Patient In Mino-Lok Late Stage Trial

Feb 15 (Reuters) - Citius Pharmaceuticals Inc:

* CITIUS ANNOUNCES ENROLLMENT OF FIRST PATIENT IN THE MINO-LOK™ PHASE 3 TRIAL

* CITIUS PHARMACEUTICALS - WHEN FULLY-RECRUITED, PLANNED THERE WILL BE 700 PATIENTS ENROLLED IN 50 PARTICIPATING INSTITUTIONS, THROUGHOUT U.S IN TRIAL Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below